Spiration Pulls in $7 Million Debt Financing For Device to Treat Lung Diseases

Bookmark and Share

Xconomy.com -- Spiration, the Redmond, WA-based maker of a device to treat deadly lung diseases like emphysema and chronic bronchitis, has raised $7 million in debt out of a $10 million financing, according to a regulatory filing.

MORE ON THIS TOPIC